TILT Biotherapeutics Ltd is the leading company globally working in the area of enabling tumor.
TILT Biotherapeutics has raised $25.3M in total funding. The most recent round was Series B. The last funding was announced in May 2025.
TILT Biotherapeutics's investors include Lifeline Ventures, Tesi, Business Finland, European Innovation Council, U.S. Department of Defense.
TILT Biotherapeutics is headquartered in Helsinki, Finland.
TILT Biotherapeutics Ltd is the leading company globally working in the area of enabling tumor.
TILT Biotherapeutics is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"TILT Biotherapeutics — Funding & Investors." VCBacked, May 13, 2025, https://www.vcbacked.co/company/tilt-biotherapeutics. Accessed July 19, 2026.
VCBacked. (2025). TILT Biotherapeutics — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/tilt-biotherapeutics
{{cite web |title=TILT Biotherapeutics — Funding & Investors |url=https://www.vcbacked.co/company/tilt-biotherapeutics |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated